STOCKHOLM, Sweden--(BUSINESS WIRE)--Regulatory News:
Addtech Life Science, a business area in the Addtech Group (STO:ADDTB), has acquired all the shares in Fenno Medical Oy via Mediplast AB.
Fenno Medical is a leading medtech actor in the Finnish market, marketing a broad range of medical equipment and consumables from world-leading suppliers. The company also sells a selected range of laboratory products. Customers are mainly found in public healthcare as well as in academic research and industry. Fenno Medical has around 35 employees and sales of approximately EUR 20 million.
The acquisition entails strategic expansion in the Finnish market, boosting Mediplast’s and thus Addtech Life Science’s position as a leading Nordic medtech supplier.
The acquisition will take effect immediately and is expected to have a marginally positive effect on Addtech’s earnings per share during the current year.
Stockholm, 1 July, 2015 Addtech AB (publ)
This information was brought to you by Cision http://news.cision.com